Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT® Re-usable Inhaler

Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler

(2019) Rajiv Dhand et al.   International Journal of Chronic Obstructive Pulmonary Disease

International comparison of health care carbon footprints

(2019) Peter-Paul Pichler et al.   Environmental Research Letters

ENVIRONMENTAL IMPACT ASSESSMENT OF A HEALTH TECHNOLOGY: A SCOPING REVIEW

(2018) Julie Polisena et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values

(2017) Melissa J. Armstrong et al.   VALUE IN HEALTH

Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions

(2017) Mark Sculpher et al.   VALUE IN HEALTH

Advancing Value Assessment in the United States: A Multistakeholder Perspective

(2017) Corinna Sorenson et al.   VALUE IN HEALTH

Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes

(2017) Rob Baltussen et al.   VALUE IN HEALTH

Evaluating Frameworks That Provide Value Measures for Health Care Interventions

(2017) Jeanne S. Mandelblatt et al.   VALUE IN HEALTH

Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis

(2017) Louis P. Garrison et al.   VALUE IN HEALTH

Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

(2017) Natalia Hawken et al.   BMC Pulmonary Medicine

Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices

(2016) Federico Lavorini et al.   DRUGS & AGING

INCORPORATING ENVIRONMENTAL OUTCOMES INTO A HEALTH ECONOMIC MODEL

(2016) Kevin Marsh et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

(2016) Gillian D. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Expanding Health Technology Assessments to Include Effects on the Environment

(2016) Kevin Marsh et al.   VALUE IN HEALTH

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®

(2016) P.N. Richard Dekhuijzen et al.   Patient Preference and Adherence

Switching from branded to generic inhaled medications: potential impact on asthma and COPD

(2013) Federico Lavorini et al.   Expert Opinion on Drug Delivery

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

(2013) Sean D. Sullivan et al.   VALUE IN HEALTH

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist™ Inhaler

(2012) Rick Hodder   International Journal of Chronic Obstructive Pulmonary Disease

COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population

(2011) Monica J Fletcher et al.   BMC PUBLIC HEALTH

Retail sales of inhalation devices in European countries: So much for a global policy

(2011) F. Lavorini et al.   RESPIRATORY MEDICINE

Estimate of the Carbon Footprint of the US Health Care Sector

(2009) Jeanette W. Chung et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Costing and Perspective in Published Cost-Effectiveness Analysis

(2009) Peter J. Neumann   MEDICAL CARE

The ADMIT series — Issues in Inhalation Therapy. 4) How to choose inhaler devices for the treatment of COPD

(2009) Walter Vincken et al.   Primary Care Respiratory Journal

Global strategy for asthma management and prevention: GINA executive summary

(2008) E. D. Bateman et al.   EUROPEAN RESPIRATORY JOURNAL